Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Anthera Pharmaceuticals Company Profile (NASDAQ:ANTH)

Consensus Ratings for Anthera Pharmaceuticals (NASDAQ:ANTH) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.75 (97.77% upside)

Analysts' Ratings History for Anthera Pharmaceuticals (NASDAQ:ANTH)
Show:
DateFirmActionRatingPrice TargetActions
5/20/2015Citigroup Inc.UpgradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Citigroup Inc.UpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015Piper JaffrayBoost Price Target$7.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Jefferies GroupReiterated RatingBuy$18.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2013 forward)